Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 52025M11986

Prior notification of a concentration (Case M.11986 – KKR / STONEPEAK / ASSURA) – Candidate case for simplified procedure

PUB/2025/573

OJ C, C/2025/3001, 27.5.2025, ELI: http://data.europa.eu/eli/C/2025/3001/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2025/3001/oj

European flag

Official Journal
of the European Union

EN

C series

C/2025/3001

27.5.2025

Prior notification of a concentration

(Case M.11986 – KKR / STONEPEAK / ASSURA)

Candidate case for simplified procedure

(Text with EEA relevance)

(C/2025/3001)

1.   

On 21 May 2025, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

—

KKR & Co. Inc. (‘KKR & Co.’ USA),

—

Stonepeak Partners LP (‘Stonepeak’, USA) controlled by Michael Dorrell, and

—

Assura plc (the ‘JV’, UK).

KKR and Stonepeak will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of the JV.

The concentration is accomplished by way of public bid announced on 9 April 2025.

2.   

The business activities of the undertakings concerned are the following:

—

KKR is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions,

—

Stonepeak is a global alternative investment firm specializing in infrastructure and real assets,

—

the JV is a specialist healthcare property investor and developer.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed concentration to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.11986 – KKR / STONEPEAK / ASSURA

Observations can be sent to the Commission by email or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

(1)   OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)   OJ C 160, 5.5.2023, p. 1.

ELI: http://data.europa.eu/eli/C/2025/3001/oj

ISSN 1977-091X (electronic edition)

Top